AstraZeneca’s Pascal Soriot awarded British knighthood for services to UK
AstraZeneca also played a critical role in the global response to COVID-19.
AstraZeneca also played a critical role in the global response to COVID-19.
Each company will share operational data with Evinova, feeding the platform’s AI engines to provide benchmarks and actionable insights, aiming to speed up trials while maintaining top-tier patient care
UK Prime Minister Keir Starmer praised the initiative, saying: “Unlocking opportunities for British businesses across the globe and delivering for working people back home is always the driving force behind my international engagements."
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies
Subscribe To Our Newsletter & Stay Updated